Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds JP Morgan Upgrades Solid Biosciences to Neutral

JP Morgan Upgrades Solid Biosciences to Neutral

JP Morgan analyst Anupam Rama upgrades Solid Biosciences (NASDAQ:SLDB) from Underweight to Neutral.

byBenzinga Newsdesk

September 30, 2022

1 minute read

JP Morgan analyst Anupam Rama upgrades Solid Biosciences (NASDAQ:SLDB) from Underweight to Neutral.

After Meta, Google Issues Notice To Bring Employees Back To Office

By Ananya Gairola

June 8, 5:41 AM

Following in the footsteps of Meta Platforms Inc. (NASDAQ:META), Alphabet Inc. (NASDAQ:GOOG) (NASDAQ:GOOGL) has reportedly issued a notice asking employees to return to the…

CRM

Oppenheimer Maintains Outperform on SPX Technologies, Raises Price Target to $82

By Benzinga Newsdesk

February 24, 8:37 AM

Oppenheimer analyst Bryan Keane maintains SPX Technologies (NYSE:SPXC) with a Outperform and raises the price target from $77 to $82.

SPXC

Analyst Ratings

What 9 Analyst Ratings Have To Say About Extreme Networks

By Benzinga Insights

September 18, 3:00 PM

Extreme Networks (NASDAQ:EXTR) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat…

EXTR

Jim Cramer Says No To This Fintech Titan With Declining Margins: ‘I Think It’s A Value Trap’

By Priya Nigam

September 12, 8:21 AM

On CNBC’s "Mad Money Lightning Round," Jim Cramer said ONEOK, Inc's (NYSE: OKE) management is terrific. "The CFO Walter Hulse is like you and me, a Jersey-ite.

ALB

JP Morgan Upgrades Solid Biosciences to Neutral

Related Posts

After Meta, Google Issues Notice To Bring Employees Back To Office

Oppenheimer Maintains Outperform on SPX Technologies, Raises Price Target to $82

What 9 Analyst Ratings Have To Say About Extreme Networks

Jim Cramer Says No To This Fintech Titan With Declining Margins: ‘I Think It’s A Value Trap’